PearlsInMires is actively pursuing research and development using ADP-Ribose modulation platform technology to target various diseases.
Our ADP-Ribose modulation platform has the potential to enhance or replace existing treatments. At PearlsInMires, we are advancing technology to overcome the limitations of current therapeutics, such as toxicity and resistance. Our goal is to improve the quality of life for patients and make managing severe diseases as manageable as treating a common illness.